Evidence map›Paper›PMID 36620381›Full record

ArticleFrontiers in surgery2022

Preoperative tumor marking with indocyanine green prior of robotic colorectal resections.

Michael K Konstantinidis, Argyrios Ioannidis, Pantelis Vasiliou, Nikolaos Arkadopoulos, Ioannis S Papanikolaou, Manish Chand, Tom Pampiglione, Dimitrios Karagiannis, Konstantinos Konstantinidis

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Michael K KonstantinidisDepartment of General, Laparoscopic, Oncologic and Robotic Surgery, Athens Medical Center, Athens, Greece.
Argyrios IoannidisDepartment of General, Laparoscopic, Oncologic and Robotic Surgery, Athens Medical Center, Athens, Greece.
Pantelis VasiliouFourth Department of Surgery, Attikon University Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Nikolaos ArkadopoulosFourth Department of Surgery, Attikon University Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Ioannis S PapanikolaouHepatogastroenterology Unit, Second Department of Internal Medicine - Propaedeutic, Medical School, National and Kapodistrian University of Athens, Attikon University General Hospital, Athens, Greece.
Manish ChandUCL Division of Surgery and Interventional Sciences, WEISS Centre, University College London, London, United Kingdom.
Tom PampiglioneUCL Division of Surgery and Interventional Sciences, WEISS Centre, University College London, London, United Kingdom.
Dimitrios KaragiannisDepartment of Gastroenterology and Hepatology, Athens Medical Center, Athens, Greece.
Konstantinos KonstantinidisDepartment of General, Laparoscopic, Oncologic and Robotic Surgery, Athens Medical Center, Athens, Greece.
Athens Medical Center · GRNational and Kapodistrian University of Athens · GRUniversity College London · GBWellcome / EPSRC Centre for Interventional and Surgical Sciences · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This prospective case-series study aimed to assess the usefulness of preoperative colonoscopic marking of colorectal tumors using Indocyanine Green (ICG) fluorescence in patients that underwent robotic surgical colorectal resections. Consecutive patients that were eligible for colorectal resection with intent to cure in a single hospital (Athens Medical Center), from February 2022 to June 2022, were included. ICG solution was injected into the submucosal layer at 2 opposite sites (180 degrees apart) distal to the tumor, without submucosal elevation. Identification of the tumor marking was then performed after switching to near-infrared (NIR) fluorescence mode. During the robotic procedure, qualitative evaluation of fluorescence was performed by the surgical team (primary surgeon, first assistant, second assistant, research fellow). All 10 patients underwent robotic surgical approach and operations included right-sided colectomy (

Indexed as

colorectal surgeryfluorescent guided surgeryindocyanine greennear-infrared fluorescence imaging systemrobotic surgery

Identifiers

PMID36620381
PMCPMC9815600
OpenAlexW4312188132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.